cGAS inhibitor therapy(Nimbus Therapeutics)

N/A

Report date: 2024/01/26 17:37:07

Base Information

Drug NamecGAS inhibitor therapy(Nimbus Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic GMP-AMP synthase inhibitors
TargetsCyclic GMP-AMP synthase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNimbus Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNimbus Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A